Skip to content

Pathway and Urgent caRe of Dyspneic Patient at the Emergency Department in LorrainE District (PURPLE)

Pathway and Urgent caRe of Dyspneic Patient at the Emergency Department in LorrainE District

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03194243
Acronym
PURPLE
Enrollment
75000
Registered
2017-06-21
Start date
2017-10-05
Completion date
2023-10-31
Last updated
2017-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Dyspnea

Keywords

acute dyspnea, acute heart failure, emergency

Brief summary

This is an observational prospective multicenter study of patients admitted for acute dyspnea in an emergency department of the participating centers in the Lorraine district. The primary objective is to assess the outcome of this population according to the cause of acute dyspnea as well as identify the predictors of this outcome, both overall and according to each acute dyspnea cause.

Detailed description

This observational prospective multicenter study will be conducted using data from electronic medical records, acquired as part of usual care, in patients admitted for acute dyspnea in the emergency department. Clinical, treatment, laboratory and imaging data acquired during the hospitalization (in the emergency department and in the department that admitted the patients following the emergency department stay) will be collected. Vital status will be recorded at 30 days and 1 year post-admission.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men or women \> or = 18 years. * Patients with acute dyspnea admitted for acute dyspnea in the emergency department. * Patient informed.

Exclusion criteria

* Cardiorespiratory arrest. * Patient having expressed his or her opposition.

Design outcomes

Primary

MeasureTime frame
All cause mortalityFrom emergency admission for acute dyspnea up until 1 year

Secondary

MeasureTime frameDescription
Clinical datathrough hospital stay, an average of 10 days
Treatment datathrough hospital stay, an average of 10 days
Laboratory datathrough hospital stay, an average of 10 days
Imaging datathrough hospital stay, an average of 10 days
Duration of hospitalizationAt final discharge, an average of 10 days after admissionincluding emergency stay and conventional hospitalization
Initial diagnosis in the emergency departmentAt admission
Final diagnosis of the initial hospitalization stayAt final discharge, an average of 10 days after admission
Brain Natriuretic PeptideThrough hospital stay, an average of 10 days
Estimated glomerular function rateThrough hospital stay, an average of 10 days
Estimated plasma volumeThrough hospital stay, an average of 10 days
Demographic datathrough hospital stay, an average of 10 days
UreaThrough hospital stay, an average of 10 days
Use of non-invasive ventilationThrough hospital stay, an average of 10 days
Time of use of non-invasive ventilationThrough hospital stay, an average of 10 days
Use of diureticsThrough hospital stay, an average of 10 days
Time of use of diureticsThrough hospital stay, an average of 10 days
Use of nitratesThrough hospital stay, an average of 10 days
Time of use of nitratesThrough hospital stay, an average of 10 days
Department type admitting the patient following emergency managementThrough hospital stay, an average of 10 daysintensive care unit, cardiology, cardiac intensive care unit, other ...
All cause in-hospital mortalityAt final discharge, an average of 10 days after admission
Liver biological biomarkersThrough hospital stay, an average of 10 days

Countries

France

Contacts

Primary ContactTahar CHOUIHED, MD
t.chouihed@chru-nancy.fr+ 33 3 83 85 14 96
Backup ContactNicolas GIRERD, MD,PhD
n.girerd@chru-nancy.fr+ 33 3 83 15 74 96

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026